跳至主要内容
临床试验/NCT03665090
NCT03665090Unknown不适用

A Three-year Community-based Study in Diabetes: The Shanghai Cohort Study of Diabetic Eye Disease

Shanghai Eye Disease Prevention and Treatment Center0 个研究点目标入组 8,000 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
8,000
主要终点
Prevalence and incidence rate of diabetic eye disease

研究概览

简要总结

To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.

详细描述

The Shanghai Cohort study of Diabetic Eye disease (SCODE) was a three-year community-based study to carry out a regular ocular health screening and epidemiological analysis for diabetic eye disease in the approximately 8,000 middle-aged and elderly people with diabetes in Shanghai. Through this study, we hope to understand the prevalence, epidemic trend and the features of risk factors distribution on diabetic eye disease, especially on DR.

Meanwhile, our aims also included estimating the ocular fundus changes and visual impairment associated with different grade of DR. Furthermore, the aim of the present study was to investigate the association between serum and urine biochemical parameters and DR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with diabetes aged 35 years and above; under archives management; residing in Shanghai.

排除标准

  • All the study participants have difficulties of mobility or communication.

结局指标

主要结局

Prevalence and incidence rate of diabetic eye disease

时间窗: December 31, 2018

SCODE was performed to evaluate the prevalence and rate of new cases of diabetic eye disease, especially DR, in a three-year community-based cohort study for the people with diabetes, and to identify the associated factors related with diabetic eye disease.

次要结局

  • Urine biochemistry indexes(December 31, 2018)
  • Visual impairment(December 31, 2018)
  • Retinal and choroidal thickness(December 31, 2018)
  • Grading of DR(December 31, 2018)
  • Retinal blood flow(December 31, 2018)
  • Blood biochemistry indexes(December 31, 2018)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiannan Huang

Principal Investigator

Shanghai Eye Disease Prevention and Treatment Center

相似试验